Skip to Content

UK Edition. Click here for US version.

MEDOMON XL 60MG PROLONGED RELEASE TABLETS

Active substance(s): ISOSORBIDE 5-MONONITRATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Space for Pharmacode

Medomon XL 60mg
Prolonged release tablets
Isosorbide Mononitrate

Take special care with Medomon XL Tablets

1.
2.
3.
4.
5.
6.

What Medomon XL Tablets are and what are they used for
Before you take Medomon XL Tablets
How to take Medomon XL Tablets
Possible side effects
How to store Medomon XL Tablets
Further information

1.

What Medomon XL Tablets are and what are they used for

Medomon XL Tablets.

Medomon XL Tablets belong to a group of medicines called Nitrates.

2.

Medomon XL Tablets is used to prevent attacks of angina, and should

Medomon XL Tablets if are taking:

Before you take Medomon XL Tablets

Do not take Medomon XL Tablets if you:

Medomon XL Tablets if you are pregnant,

You may experience dizziness when you start taking Medomon XL Tablets. You should
therefore know how you react to Medomon XL Tablets before you drive or use machines.

Space for Pharmacode

Title: Art Work Approval Form

MEDREICH LIMITED

Specification: Printed on 56 - 60 GSM maplitho paper

Product

Medomon XL Tablets - 60 mg - S/L - Eng - PIL

Customer

MEDREICH PLC, UK

Reason
for Issue

New PIF
New Product

Colours:

Single - Black

Dimensions:

280 x 210 mm (Open size)

Layout No.

NA

No. of Folds

Item Code

120XXXX (WOA)

Artwork No.:

NA

Artwork made to

75%

Dimensions & Colour Shade: Confirmed by PDC

Check for all aspects

100% check
on text matter:

Check on design and
adequacy of text matter:

Check on Dimensions
& OPD aspects:

Check on Label claim, License, Codes aspects:

PDC

Regulatory :

IBD:

Technical services:

QC:

WIN\\192.168.1.32\pdc\Artworks\Medreich\UK Products\Medomil\PILMedom XL Tablets 60mg SL English PIL_04.04.12.ai
MED/ISMN/PIL/08
Format No.: CO-QA005-F06-00
CD issued on
Internal Approval issued on

CQA:
10.01(SK)03.02(GW)/05.03(MA)/
28.10.11(MA)/05.01.11(MA)/02(MA)/
13.02(MA)/04(MA)17.04.12(MA)

Changes:
04.04.12 1) Revised Brand name from
Medomil to Medomon
2) 04.04.12 - Revised Isosorbide
mononitrate in place of
isosorbide-5-mononitrate below
to main product name &
Date changed to April 2012
3) 17.04.12 Revision in Main heading

Space for Pharmacode

Medomon XL Tablets

3.

How to take Medomon XL Tablets

Always take Medomon XL Tablets exactly as your doctor has told you. You should
check with your doctor or pharmacist if you are not sure.

5.

How to store Medomon XL Tablets

If you take more Medomon XL Tablets than you should

What Medomon XL Tablets contain
If you forget to take Medomon XL Tablets
What Medomon XL Tablets looks like and contents of the pack
If you stop taking Medomon XL Tablets

Like all medicines Medomon XL Tablets can cause side effects, although not
everybody gets them.

Marketing Authorisation Holder and Manufacturer:
Medreich Plc
9, Royal Parade, Kew Gardens,
Surrey TW9 3QD, England
P
This leaflet was last approved in April 2012

120XXXX

Space for Pharmacode

Title: Art Work Approval Form

MEDREICH LIMITED

Specification: Printed on 56 - 60 GSM maplitho paper

Product

Medomon XL Tablets - 60 mg - S/L - Eng - PIL

Customer

MEDREICH PLC, UK

Reason
for Issue

New PIF
New Product

Colours:

Single - Black

Dimensions:

280 x 210 mm (Open size)

Layout No.

NA

No. of Folds

Item Code

120XXXX (WOA)

Artwork No.:

NA

Artwork made to

75%

Dimensions & Colour Shade: Confirmed by PDC

Check for all aspects

100% check
on text matter:

Check on design and
adequacy of text matter:

Check on Dimensions
& OPD aspects:

Check on Label claim, License, Codes aspects:

PDC

Regulatory :

IBD:

Technical services:

QC:

WIN\\192.168.1.32\pdc\Artworks\Medreich\UK Products\Medomil\PILMedom XL Tablets 60mg SL English PIL_04.04.12.ai
MED/ISMN/PIL/08
Format No.: CO-QA005-F06-00
CD issued on
Internal Approval issued on

CQA:
10.01(SK)03.02(GW)/05.03(MA)/
28.10.11(MA)/05.01.11(MA)/02(MA)/
13.02(MA)/04(MA)17.04.12(MA)

Changes:
04.04.12 1) Revised Brand name from
Medomil to Medomon
2) 04.04.12 - Revised Isosorbide
mononitrate in place of
isosorbide-5-mononitrate below
to main product name &
Date changed to April 2012
3) 17.04.12 Revision in Main heading

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide